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Neural crest cells undergo a spatiotemporally regulated epithelial-to-mesenchymal transition (EMT) that proceeds head to 
tailward to exit from the neural tube. In this study, we show that the secreted molecule Draxin is expressed in a transient 
rostrocaudal wave that mirrors this emigration pattern, initiating after neural crest specification and being down-regulated 
just before delamination. Functional experiments reveal that Draxin regulates the timing of cranial neural crest EMT by 
transiently inhibiting canonical Wnt signaling. Ectopic maintenance of Draxin in the cranial neural tube blocks full EMT; while 
cells delaminate, they fail to become mesenchymal and migratory. Loss of Draxin results in premature delamination but also 
in failure to mesenchymalize. These results suggest that a pulse of intermediate Wnt signaling triggers EMT and is necessary 
for its completion. Taken together, these data show that transient secreted Draxin mediates proper levels of canonical Wnt 
signaling required to regulate the precise timing of initiation and completion of cranial neural crest EMT.
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Introduction
The neural crest is a stem cell population that originates within 
the forming central nervous system but subsequently delami-
nates from the neuroepithelium by undergoing a spatiotempo-
rally regulated epithelial-to-mesenchymal transition (EMT) with 
a sequence of initiation that progresses from rostral to caudal. 
In amniotes, the process of neural crest emigration starts at the 
level of the caudal forebrain/rostral midbrain and then propa-
gates progressively caudally. After delamination, mesenchymal 
neural crest cells migrate sometimes long distances to populate 
numerous sites in the periphery, where they differentiate into 
many different cell types including peripheral ganglia, melano-
cytes of the skin, and bone and cartilage of the face (Green et 
al., 2015; Martik and Bronner, 2017; Gandhi and Bronner, 2018).
The mechanisms of neural crest EMT appear to differ at dif-
ferent levels of the body axis, with cranial neural crest cells un-
dergoing a more collective emigration process whereas trunk 
neural crest cells delaminate as individuals (Théveneau et al., 
2007). Consistent with this, cranial neural crest cells possess dif-
ferent gene regulatory subcircuits than trunk neural crest cells 
(Simoes-Costa and Bronner, 2016); for example, the premigratory 
cranial but not trunk neural crest expresses transcription factors 
like the Wnt effector Axud1 (Simões-Costa et al., 2015) and Ets-1, 
proposed to confer collective EMT (Théveneau et al., 2007).
Several secreted factors (e.g., FGFs, BMPs, and Wnts) have 
been proposed to regulate various aspects of neural crest spec-
ification, delamination/EMT, and migration. For example, cra-
nial neural crest specification is thought to require intermediate 
levels of BMP signaling together with canonical Wnt signaling 
(Tribulo et al., 2003; Steventon et al., 2009; Steventon and Mayor, 
2012). The latter is mediated by the transcription factor Axud1, 
which then directly interacts with neural plate border genes 
Pax7 and Msx1 to activate neural crest specifier genes (Simões-
Costa et al., 2015). Wnt signaling is also critical for controlling 
proliferation of neural crest precursors in the dorsal neural tube 
(Dickinson et al., 1995). Later, noncanonical Wnt signaling is 
essential for neural crest migration (Carmona-Fontaine et al., 
2008a; Matthews et al., 2008), whereas canonical Wnt signaling 
is involved in lineage specification, with high Wnt biasing neural 
crest cells toward neuronal differentiation and low Wnt toward 
mesenchymal derivatives (Hari et al., 2012). However, it has been 
difficult to separate the effects of these factors on these different 
processes given that they occur sequentially, particularly because 
blocking specification can indirectly influence later events. An 
important unanswered question is how Wnt signaling controls 
so many different aspects of neural crest development.
In this study, we focus on how neural crest precursor cells 
transition from specification to EMT by examining the mecha-
nisms underlying initiation of neural crest EMT along the neural 
axis. We show that the secreted molecule Draxin is expressed in 
a transient rostrocaudal wave within the premigratory neural 
crest and that its down-regulation mirrors initiation of cranial 
neural crest emigration. Intriguingly, ectopic maintenance of 
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Draxin in the cranial neural tube inhibits emigration. In prob-
ing the molecular mechanism, we find that modulating Draxin 
expression alters canonical Wnt reporter activity in vivo and 
that Draxin interacts with the canonical Wnt coreceptor LRP5. 
Maintenance of Draxin blocks the emigration process, whereas 
its loss results in premature delamination, but both gain and 
loss block mesenchymalization. Collectively, these data suggest 
that a transient pulse of intermediate Wnt signaling mediated 
by Draxin is required for proper neural crest EMT. Thus, Draxin 
acts as a rheostat that transiently inhibits canonical Wnt sig-
naling to correctly time cranial neural crest delamination and 
completion of EMT.
Results
Draxin expression tightly correlates with cranial 
neural crest EMT
Draxin was identified in a screen for genes enriched in premigra-
tory cranial neural crest cells but intriguingly was absent from 
migrating cranial neural crest cells (Simões-Costa et al., 2014). To 
elucidate its spatiotemporal expression pattern, we performed 
whole-mount in situ hybridization and first detected Draxin at 
Hamburger–Hamilton stage 9− (HH9−) in the dorsal neural tube 
within the region that will give rise to the cranial neural crest 
(Fig. 1 A). The Draxin expression domain expanded more cau-
dally by HH9, following the rostrocaudal progression of neural 
crest development, while remaining restricted to the dorsal neu-
ral folds (Fig. 1 B). By HH9+, Draxin was down-regulated within 
the cranial neural crest, though its expression persisted further 
caudally (Fig. 1 C).
To better define its expression relative to the progression of 
cranial neural crest development, we compared expression pat-
terns for the neural crest markers Pax7 and HNK-1 with Draxin. 
Pax7 is an early marker for the neural plate border and premi-
gratory neural crest, and it persists in early migrating neural 
crest cells (Basch et al., 2006; Betancur et al., 2010a), whereas 
HNK-1 marks migratory neural crest cells that have exited the 
neural tube and completed EMT (Bronner-Fraser, 1986). Im-
munohistochemical analysis revealed that Pax7 expression at 
HH9−/9 preceded and subsequently overlapped with Draxin ex-
pression within the neural folds (Fig. 1, D and E; compare with 
Fig. 1, G and H). By HH9+, a wave of migratory neural crest was 
observed, restricted to the cranial level (mesencephalon through 
the second rhombomere) of neural tube as indicated by HNK-1 
labeling (Fig. 1 F). Notably, robust staining for HNK-1 at HH9+ co-
incided with a loss of endogenous Draxin from the cranial neural 
folds (Fig. 1 I). Thus, Draxin is expressed in a transient fashion 
within the neural folds, initiating after neural crest specifica-
tion (Simões-Costa et al., 2015), and then it is rapidly down-reg-
ulated before EMT.
Draxin knockdown induces premature delamination of 
cranial neural crest
Because of the mutually exclusive expression of HNK-1 and 
Draxin and because Draxin is specifically expressed within pre-
migratory cranial neural crest cells, we hypothesized that Draxin 
must be down-regulated for cranial neural crest EMT to proceed. 
To test its function within premigratory neural crest, we knocked 
down Draxin using an antisense morpholino (MO)-mediated 
knockdown approach. To this end, we performed unilateral HH4 
electroporations with either a control MO (Fig. 2 A) or a trans-
lation-blocking Draxin MO (Fig. 2 B). Loss of Draxin caused de-
fects in cranial neural crest emigration at stage HH9+ compared 
with control, reducing the distance neural crest traveled away 
from the midline (Fig. 2 C; 60.2 ± 3.1% vs. 86.5 ± 1.9% of the rela-
tive maximum migration distance of the unelectroporated side, 
respectively). The penetrance of this phenotype was similar to 
CRI SPR/Cas9-mediated Draxin knockdown (Fig. S1, A–C). Draxin 
loss of function had no effect on the levels of cell death or prolif-
eration (Fig. S1, D–I).
To parse the mechanistic events that caused this emigration 
phenotype, we examined cross sections of the dorsal neural tube 
of MO-electroporated embryos at stage HH9+. Pax7 immunostain-
Figure 1. Draxin is expressed in premigratory cranial neural crest and 
down-regulated at the onset of EMT. (A–C) Representative images of chro-
mogenic whole-mount in situ hybridization for Draxin in stage HH9− (A and 
A’), HH9 (B and B’), and HH9+ (C and C’) chick embryos. Dotted lines in A, B, 
and C indicate cross sections shown in A’, B’, and C’, respectively. (D–F) Immu-
nostaining for Pax7 (green) and HNK1 (magenta) in stage-matched embryos. 
(G–I) Fluorescent in situ hybridization for Draxin (cyan) with immunostaining 
for HNK1 (magenta) in stage-matched embryos. Bars, 100 µm.
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ing revealed increased cranial neural crest delamination (i.e., de-
parture from the neuroepithelium) with Draxin knockdown (133.9 
± 10.7% of the control) as well as reduced neural crest retention 
within the dorsal neural tube (65.5 ± 4.2% of the control), although 
the total number of Pax7+ cells was unchanged (Fig. 2, D and F). To 
identify potential downstream effects on neural crest specifica-
tion, we also examined the early neural crest specifier genes Snail2 
and Sox9, both of which are expressed in premigratory neural 
crest following Pax7 (Betancur et al., 2010a). In contrast with Pax7, 
Draxin knockdown resulted in a decrease in the total numbers of 
Snail2+ and Sox9+ cells (78.6 ± 3.5% and 68.0 ± 8.1% of the control, 
respectively; Fig. 3, A–F). Further, whereas both exhibited reduced 
neural crest retention within the dorsal neural tube (48.2 ± 5.1% 
and 63.4 ± 10.9% of the control, respectively), the number of Sox9+ 
cells that had delaminated was also decreased (Fig. 3, D and F; 67.7 
± 7.6% of the control). Interestingly, the number of Snail2+ cells 
that delaminated was not significantly different from the control 
(Fig. 3, B and E); moreover, quantification of the relative fluores-
cence intensity of the delaminated Snail2+ cells revealed a signifi-
cant increase in the level of Snail2 after Draxin knockdown (Fig. 3, 
B and B′; 167.1 ± 2.0% of the control; P = 0.0004, two-tailed t test).
Given that Snail2 has long been established as a regulator of 
EMT (Nieto et al., 1994), we next examined the effects of Draxin 
knockdown on the expression of Cadherin 6B (Cad6B), which is 
a direct target of Snail2 (Taneyhill et al., 2007; Strobl-Mazzulla 
and Bronner, 2012) and whose expression in premigratory neu-
ral crest is down-regulated during EMT, paralleling Draxin ex-
pression (Nakagawa and Takeichi, 1995). Quantitation of Cad6B 
immunostaining showed a significant decrease in the level of 
Cad6B protein in the dorsal neural tube at premigratory stages 
after Draxin knockdown (Fig. 3, G–I; 41.0 ± 2.1% of the control), 
which may account for the increased delamination observed in 
Draxin MO–electroporated embryos. Taken together, these data 
suggest that Draxin is necessary to retain premigratory neural 
crest within the dorsal neural tube and maintain the appropriate 
level of expression of neural crest specifier genes.
Despite the increased detachment from the neural tube after 
loss of Draxin, we hypothesized that the delaminated neural 
crest cells failed to complete EMT to become mesenchymal and 
migratory. To test this, we examined expression of the migra-
tory neural crest marker, HNK-1, which is expressed on migra-
tory neural crest cells after the delamination and completion of 
EMT (Bronner-Fraser, 1986; Giovannone et al., 2015). Indeed, we 
observed robust expression of HNK-1 on control-treated neural 
crest cells that had mesenchymalized and begun their emigra-
tion away from the neural tube (Fig. 3 I). In contrast, Draxin MO–
Figure 2. Draxin knockdown caused cranial 
neural crest to prematurely delaminate and 
accumulate at the dorsal midline. (A and B) 
Representative images for Pax7 immunostaining 
(green) in embryos unilaterally electroporated 
with FITC-labeled (magenta) control MO (A) 
or a translation-blocking Draxin MO (B). Bars, 
100 µm. Arrowhead highlights defects in neural 
crest emigration resulting from perturbation. (C) 
Quantification of relative maximum migration 
distance indicated Draxin knockdown (B) signifi-
cantly reduced the emigration of Pax7+ neural 
crest cells from the neural tube compared with 
control (A). Each circle represents the average of 
six measurements per embryo taken over a 300-
µm anterior-to-posterior region of cranial neural 
crest (n = 11 and n = 17 control MO and Draxin 
MO embryos, respectively). *, P < 0.0001; two-
tailed t test. Black bars indicate mean ± SEM. (D 
and E) Representative cross sections of embryos 
electroporated with control MO (D) or Draxin 
MO (E) immunostained for Pax7 (green) at HH9+. 
To visually compare the number of Pax7+ neural 
crest cells undergoing delamination, the extreme 
dorsal aspect of the neural tube epithelium is 
indicated by a dotted line. Bars, 20 µm. (F) Quan-
tification of Pax7+ cells on electroporated versus 
unelectroporated sides of embryo (three sec-
tions/embryo; n = 3 embryos/condition) yielded 
no significant difference (P = 0.36, two-tailed t 
test) in total Pax7+ cells between control MO and 
Draxin MO–electroporated embryos, although 
a significant increase in Pax7+ cells that delami-
nated and left the dorsal neural tube (*, P = 0.04; 
two-tailed t test), and a significant decrease in 
Pax7+ cells that were retained within the dorsal 
neural tube (*, P = 0.003; two-tailed t test) were 
observed with Draxin knockdown. Black bars 
indicate mean ± SEM.
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electroporated embryos displayed a significant loss of the HNK-1 
epitope (Fig. 3, K and L; 30.5 ± 7.6% of the control). Thus, these 
data suggest that Draxin is required within premigratory neural 
crest to control the precise timing of EMT onset and completion.
Ectopic maintenance of Draxin inhibits cranial neural crest 
EMT but not specification
Given that Draxin expression appears to be tightly regulated 
during neural crest development, we asked whether prolonging 
the expression of Draxin such that it persists during EMT would 
negatively affect cranial neural crest migration. To this end, we 
subcloned full-length chick Draxin with a C-terminal FLAG tag 
into an expression vector under control of a chick β-actin (CAG) 
promoter upstream of an internal ribosome entry site (IRES)-
driven H2B-RFP (pCI-H2B-RFP; Betancur et al., 2010b); when 
this construct (Draxin-FLAG) was electroporated into gastrula 
stage HH4 chick embryos, it expressed and secreted full-length, 
FLAG-tagged Draxin after its endogenous expression was turned 
off (Fig. S2, A–D). No changes were noted in cell death or prolif-
eration (Fig. S2, E–J).
To assess the effects of ectopic Draxin on neural crest mi-
gration, we individually electroporated Draxin-FLAG or pCI-
H2B-RFP (as a control) into the right side of HH4 embryos. 
After electroporation, embryos were allowed to develop to stage 
HH9+ following the onset of cranial neural crest EMT, and they 
screened for successful electroporation by H2B-RFP expression. 
Pax7 immunostaining was used to assay effects on cranial neu-
ral crest migration. We measured the relative distances Pax7+ 
cells had migrated away from the midline compared with the 
unelectroporated, contralateral control side of the same embryo. 
pCI-H2B-RFP electroporation had little or no effect on neural 
crest EMT as Pax7+ neural crest cells on the electroporated side 
migrated 95.6 ± 2.8% (n = 12) of the distance of the unelectropo-
rated side (Fig. 4, A, E, and F). In contrast, ectopic maintenance 
of Draxin significantly reduced cranial neural crest migration 
in Draxin-FLAG–electroporated embryos to 71.3 ± 2.8% (n = 17) 
of the distance of the unelectroporated side (Fig.  4, B–F; P < 
0.00001, two-tailed t test). Similar effects were noted at caudal 
levels of cranial neural crest (rostral hindbrain through rhom-
bomere 5; Fig. 4, G and G′).
Because defects in neural crest migration could result from 
errors in earlier events of neural crest development, such as in-
duction or specification, we next examined pCI-H2B-RFP and 
Draxin-FLAG–electroporated embryos in cross section at HH9+ 
to more clearly delineate how Draxin overexpression affects neu-
ral crest EMT. In pCI-H2B-RFP–electroporated embryos, migra-
tory cranial neural crest delaminated from the dorsal neural tube 
and underwent mesenchymalization (i.e., detached from each 
other and migrated away from the neural tube) to complete EMT 
Figure 3. Draxin knockdown altered expression of EMT and neural crest 
markers. (A–F) Representative cross sections of embryos electroporated 
with control MO (A and C) or Draxin MO (B and D) immunostained for Snail2 
(A and B) and Sox9 (C and D) at HH9/9+. To visually compare the number of 
Snail2+ and Sox9+ neural crest cells undergoing delamination, the extreme 
dorsal aspect of the neural tube epithelium is indicated by a dotted line. (E and 
F) Quantification of Snail2+ (E) and Sox9+ (F) cells on electroporated versus 
unelectroporated sides of embryo (three sections/embryo; n = 3 embryos/
condition) yielded significant reductions in both the total and neural tube (NT) 
number of Snail2+ cells (*, P = 0.03 and P = 0.007, respectively; two-tailed t 
test) and Sox9+ cells (*, P = 0.02 and P = 0.03, respectively; two-tailed t test) 
between control MO and Draxin MO–electroporated embryos. Although a sig-
nificant decrease was also observed for Sox9+ cells that delaminated and left 
the dorsal neural tube (P = 0.2; two-tailed t test), no significant difference was 
observed for delaminated Snail2+ cells (P = 0.6; two-tailed t test) with Draxin 
knockdown. (G–L) Representative cross sections of embryos electroporated 
with control MO (G and J) or Draxin MO (H and K) immunostained for Cad6B 
(G and H) and HNK-1 (J and K) at HH9/9+. Quantitation of the relative fluores-
cence intensity for both Cad6B (I) and HNK-1 (L) found significant reduction 
in fluorescence intensity between control MO and Draxin MO–electroporated 
embryos (*, P = 0.0005 and P = 0.007, respectively; two-tailed t test; three 
sections/embryo; n = 3 embryos/condition). Boxes in G–K indicate zoomed 
areas in G’–K’. Arrowheads indicate ROIs for comparison. Bars, 20 µm. Dotted 
arrows in H′ and K′ illustrate changes in fluorescence intensity compared with 
control. Data are presented as mean ± SEM.
Hutchins and Bronner 
Draxin controls cranial neural crest EMT
Journal of Cell Biology
https://doi.org/10.1083/jcb.201709149
3687
(Fig. 5, A–C). However, in Draxin-FLAG–electroporated embryos, 
neural crest appeared to have delaminated to a lesser extent and 
failed to mesenchymalize, remaining adjacent to the neural tube 
and frequently tightly clumped together (Fig. 5, D–F). To deter-
mine whether the effects of Draxin overexpression were limited 
to EMT, we performed Pax7 and Sox9 cell counts and found that 
neither pCI-H2B-RFP nor Draxin-FLAG altered the total number 
of Pax7+ or Sox9+ neural crest cells on the electroporated versus 
unelectroporated side, although clear defects in the number of 
neural crests cells that delaminated from the neuroepithelium 
were observed (Fig. 5, G and I). Taken together, these data sug-
gest that Draxin antagonizes the delamination step of neural 
crest EMT, but the perdurance of its expression has no effect on 
induction or specification.
Given Draxin’s effects on EMT and its potential role as a reg-
ulator of Snail2, we also examined the expression of Snail2 with 
Draxin-FLAG overexpression. Although we observed defects in 
the number of delaminated versus neural tube Snail2+ cells sim-
ilar to those for Pax7 and Sox9 (Fig. 5, G–I), we also found a sig-
nificant reduction in the number of Snail2+ neural crest cells in 
total (Fig. 5 H). As observed with Draxin knockdown (Fig. 3), we 
detected changes in expression for both Cad6B and HNK-1 after 
Draxin overexpression. Consistent with a loss of its repressor, 
Snail2 (Fig. 5 H), Cad6B intensity was significantly up-regulated 
(Fig. 5, J–L; 129.5 ± 9.2% compared with control); interestingly, 
we observed aberrant maintenance of Cad6B expression in de-
laminated neural crest cells (Fig. 5 K′). In addition, Draxin-FLAG 
overexpression significantly reduced HNK-1 levels (Fig. 5, M–O; 
63.6 ± 8.0% compared with control). Thus, these data suggest that 
Draxin expression alters the levels of Snail2 and, consequently, 
Cad6B, to regulate the delamination of cranial neural crest. Dis-
ruption of the timing of delamination has negative consequences 
for the ability of neural crest to induce HNK-1 expression, an in-
dicator of their mesenchymalization, and ultimately impedes the 
migratory capacity of neural crest.
Cysteine-rich domain (CRD) of Draxin is necessary and 
sufficient for inhibition of cranial neural crest EMT
To parse the molecular mechanism by which Draxin inhibits 
cranial neural crest EMT, we performed deletion analysis to 
identify the functional domains of Draxin mediating its action. 
Full-length Draxin protein contains an N-terminal signal pep-
tide for secretion and a highly conserved C-terminal 60–amino 
acid CRD that has homology with the C-terminal cysteine-rich 
colipase fold domain of Dickkopf-related protein-1 (Dkk-1), the 
canonical Wnt antagonist (Fig. S3, A and B; Niehrs, 2006; Miyake 
et al., 2009). To determine whether Draxin and Dkk-1 might be 
in competition for binding partners, we performed chromogenic 
Figure 4. Draxin overexpression reduced cranial neural crest emigra-
tion from the neural tube. (A–D) Immunostaining against Pax7 (green) in 
pCI-H2B-RFP (A; control) or Draxin-FLAG–electroporated (B–D) embryos. 
H2B-RFP fluorescence (magenta) indicated successful electroporation for 
both constructs. (B–D) Representative images for mild (B), moderate (C), and 
severe (D) phenotypes of Pax7-immunostained (green) embryos unilaterally 
electroporated with Draxin-FLAG. Arrowhead in D highlights defects in neu-
ral crest emigration resulting from perturbation. (E) Quantification of phe-
notype penetrance for embryos unilaterally electroporated for pCI-H2B-RFP 
(control) or Draxin-FLAG. Data are presented as fraction of the total number 
of pCI-H2B-RFP– and Draxin-FLAG–electroporated embryos (n = 12 and n = 
17, respectively; pooled from more than three independent experiments). Rel-
ative maximum migration distance data are represented in this figure as “nor-
mal” (within SEM of pCI-H2B-RFP average), “mild” (between minimum limit 
of SEM of pCI-H2B-RFP average and maximum limit of SEM of Draxin-FLAG 
average), “moderate” (within SEM of Draxin-FLAG average), and “severe” (less 
than the minimum limit of SEM of Draxin-FLAG average). (F) Quantification of 
relative maximum migration distance indicated that Draxin-FLAG overexpres-
sion significantly reduced the emigration of Pax7+ neural crest cells from the 
neural tube compared with pCI-H2B-RFP control (A). Each circle represents 
the average of six measurements per embryo taken over a 300-µm anteri-
or-to-posterior region of cranial neural crest. *, P < 0.0001, two-tailed t test. 
Black bars, mean ± SEM. (G) Closer examination of the hindbrain region of 
a Draxin-FLAG overexpression embryo with a severe phenotype revealed a 
similar inhibition of neural crest emigration at rhombomeres 1/2 and 4 (arrow-
heads). Box in G indicates zoomed area in G’. Mes, mesencephalon; r, rhom-
bomere. Bars, 100 µm.
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Figure 5. Draxin overexpression altered expression of markers of neural crest EMT. (A–F) Cross sections of pCI-H2B-RFP (A–C; control) or Draxin-FLAG–
electroporated (D–F) embryos (magenta) immunostained for Pax7 (A and D), Snail2 (B and E), and Sox9 (C and F). To visually compare the number of Pax7+, Snail2+, 
and Sox9+ neural crest cells undergoing delamination, the extreme dorsal aspect of the neural tube epithelium is indicated by a dotted line. (G–I) Quantification of 
Pax7+ (G), Snail2+ (H), and Sox9+ (I) cells on electroporated versus unelectroporated sides of embryo (three sections/embryo; n = 3 embryos/condition). Draxin-FLAG 
overexpression yielded no significant difference in the total numbers of Pax7+ and Sox9+ cells (P = 0.13 and P = 0.6, respectively; two-tailed t test) between pCI-
H2B-RFP (A and C) or Draxin-FLAG–electroporated (D and F) embryos, although a significant decrease in Pax7+ and Sox9+ cells that delaminated and left the dorsal 
neural tube (*, P = 0.009 and P = 0.03, respectively; two-tailed t test) and a significant increase in Pax7+ cells that were retained within the dorsal neural tube (NT; *, 
P = 0.03 and P = 0.04, respectively; two-tailed t test) were observed with Draxin-FLAG overexpression. Draxin-FLAG overexpression yielded significant decreases 
in both the total and delaminated numbers of Snail2+ cells (*, P = 0.008 and P = 0.002, respectively; two-tailed t test) and a significant increase in the number of 
NT Snail2+ cells (*, P = 0.03; two-tailed t test). (J–O) Representative cross sections of embryos electroporated with pCI-H2B-RFP (J and M) or Draxin-FLAG (K and 
N) immunostained for Cad6B (J and K) and HNK-1 (M and N) at HH9/9+. Boxes in J–N indicate zoomed areas in J’–N’. Arrowheads indicate ROIs for comparison. 
Quantitation of the relative fluorescence intensity for Cad6B (L) and HNK-1 (O) found significant increase in fluorescence intensity for Cad6B with Draxin-FLAG 
overexpression (*, P = 0.04; two-tailed t test) and a significant reduction in fluorescence intensity for HNK-1 with Draxin-FLAG overexpression (*, P = 0.02; two-
tailed t test). Bars, 20 µm. Dotted arrows in K′ and N′ illustrate changes in fluorescence intensity compared with control. Data are presented as mean ± SEM.
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in situ hybridization for chick Dkk-1 (cDkk-1) at stages HH9− 
to HH9+. cDkk-1, although robustly expressed in the somites at 
these stages, was completely absent from the neural tube and, 
subsequently, migrating neural crest (Fig. S3, C–E). Thus, it is 
unlikely that Draxin is in competition with Dkk-1 during cranial 
neural crest EMT.
To test the role of Draxin’s CRD on neural crest EMT, we 
generated three mutated forms of Draxin: one coding for Drax-
in-FLAG with a deletion of the C-terminal 76 amino acids (Drax-
in-ΔCRD), one coding for only the CRD with the signal peptide 
and FLAG tag (CRD-FLAG), and one coding for only the CRD and 
FLAG tag but absent the signal peptide (CRD-ΔSP; Fig. 6 A). Elec-
troporation of Draxin-ΔCRD failed to inhibit cranial neural crest 
EMT (Fig. 4 B); the relative neural crest migration distance for 
Draxin-ΔCRD (Fig. 4 E; 92.1 ± 4.3%, n = 6) was not significantly 
different from pCI-H2B-RFP control (P = 0.81, one-way ANO VA 
with Tukey’s post hoc; compared with Fig. 4). In contrast, elec-
troporation of CRD-FLAG was sufficient to reduce relative neu-
ral crest migration (Fig. 4, C and E; 75.0 ± 3.1%, n = 7) similarly to 
full-length Draxin-FLAG (P = 0.91, one-way ANO VA with Tukey’s 
post hoc; compared with Fig.  4). Importantly, electroporation 
of CRD-ΔSP also failed to inhibit neural crest migration (Fig. 4, 
D and E; 90.5 ± 4.3%, n = 6), comparable with the pCI-H2B-
RFP control (P = 0.32, one-way ANO VA with Tukey’s post hoc; 
compared with Fig.  4). Thus, these data suggest that the CRD 
of Draxin mediates its inhibition of cranial neural crest EMT 
via secretion.
Draxin antagonizes canonical Wnt signaling in vivo
The zebrafish homologue of Draxin was previously suggested to 
be a neural-specific gene involved in stabilization of β-catenin 
during canonical Wnt signaling (Miyake et al., 2009, 2012). As 
Wnt signaling is well known to play a role in neural crest develop-
ment and EMT (García-Castro et al., 2002; Theveneau and Mayor, 
2012; Simões-Costa et al., 2015) and Draxin’s CRD has homology 
to a known canonical Wnt antagonist, we tested whether Draxin 
MO and Draxin-FLAG affected Wnt signaling during cranial 
neural crest EMT. To measure Draxin’s actions on canonical Wnt 
signaling, we coelectroporated a TCF/Lef: H2B -GFP Wnt reporter 
(Ferrer-Vaquer et al., 2010) with either control MO or Draxin MO 
(Fig. 7 A) or pCI-H2B-RFP or Draxin-FLAG (Fig. 7 B) on different 
sides of the same embryo. Quantitative Western blot analyses re-
vealed a significant increase in GFP reporter output with Draxin 
knockdown (Fig. 7 A; P < 0.0001, two-tailed t test) as well as a dras-
tic reduction in GFP reporter output with Draxin-FLAG electropo-
ration compared with control (Fig. 7 B; P = 0.015, two-tailed t test). 
To confirm that Draxin’s inhibition of canonical Wnt signaling has 
implications for neural crest EMT in vivo, next we examined cross 
sections of bilaterally electroporated embryos for reporter activity 
in cranial neural crest that were in the process of undergoing 
EMT. Neural crest cells that had successfully delaminated from the 
neural tube, yet were still adjacent to the tube and in the process 
of mesenchymalization (Fig. 7 C, circled region, left), exhibited 
qualitatively higher levels of GFP reporter output compared with 
surrounding cells with coelectroporation of pCI-H2B-RFP control. 
Figure 6. The CRD of Draxin was both neces-
sary and sufficient for its inhibition of cranial 
neural crest EMT. (A) Schematic highlighting 
important features in full-length and mutated 
FLAG-tagged Draxin constructs. Draxin contains 
an N-terminal signal peptide (SP; green) and a 
C-terminal CRD (yellow). For all constructs, a 
FLAG tag (blue) was placed at the C terminus. 
(B–D) Immunostaining against Pax7 (green) in 
Draxin-ΔCRD (B; n = 6), CRD-FLAG (C; n = 7), or 
CRD-ΔSP–electroporated (D; n = 6) embryos. 
Bars, 100 µm. Arrowhead in C′ highlights defects 
in neural crest emigration resulting from per-
turbation. (E) Quantification of relative maxi-
mum migration distance indicated expression 
of Draxin-ΔCRD (B) did not affect emigration of 
Pax7+ neural crest cells from the neural tube (P = 
0.81 vs. pCI-H2B-RFP control), whereas expres-
sion of CRD-FLAG (C) significantly reduced the 
emigration of Pax7+ neural crest cells (P = 0.001 
vs. pCI-H2B-RFP control) to levels comparable 
with full-length Draxin-FLAG (P = 0.91). Expres-
sion of CRD-ΔSP (D) had no effect on emigration 
(P = 0.75 vs. pCI-H2B-RFP control). For ease of 
visual comparison, the data for relative maximum 
migration distance for pCI-H2B-RFP and Drax-
in-FLAG from Fig. 4 are presented in this figure 
again as gray circles. Each circle represents the 
average of six measurements per embryo taken 
over a 300-µm anterior-to-posterior region of 
cranial neural crest. Statistical significance was 
determined using one-way ANO VA with Tukey’s 
post hoc test. *, P ≤ 0.01. Black bars, mean ± SEM.
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However, GFP reporter expression was markedly reduced in the 
same population of neural crest cells after coelectroporation of 
Draxin-FLAG (Fig. 7, C and D; 45.3 ± 9.0% compared with control). 
These data suggest that Draxin inhibits cranial neural crest EMT 
via modulation of canonical Wnt signaling.
Draxin genetically interacts with canonical Wnt signaling 
components to modulate EMT
In the canonical Wnt pathway, a secreted Wnt ligand binds Friz-
zled and LRP5/6 coreceptors to form a ternary complex that is 
required to stabilize β-catenin for its subsequent transcrip-
tional activities. Dkk family proteins interrupt this pathway 
by sequestering LRP5/6, thereby inhibiting β-catenin nuclear 
translocation and transcriptional activation (Niehrs, 2006). Be-
cause Draxin’s inhibition of neural crest EMT is mediated by its 
Dkk-homologous CRD and LRP5 has been shown to be necessary 
for zebrafish cranial neural crest migration (Willems et al., 2015), 
we hypothesized that Draxin antagonizes Wnt via sequestration 
of LRP5. To test this, we performed an epistasis experiment with 
full-length human LRP5 (hLRP5; MacDonald et al., 2011), which 
shares 88% amino acid identity with chick LRP5; if Draxin binds 
LRP5 to inhibit neural crest migration, overexpression of LRP5 
would be predicted to act as a molecular sponge to titrate out the 
excess exogenous Draxin, thereby rescuing EMT. Consistent with 
this, when hLRP5 is coelectroporated with Draxin-FLAG, relative 
neural crest migration is rescued to levels similar to pCI-H2B-
RFP control (Fig. 8, A and C; 89.4 ± 3.0%, n = 6). These data place 
Draxin upstream of LRP5 in the canonical Wnt pathway.
To solidify Draxin’s role in the canonical Wnt pathway during 
neural crest EMT, we sought to rescue Draxin’s inhibition of 
neural crest migration with the canonical pathway effector, 
β-catenin. To this end, we generated a gain-of-function mu-
tant construct (NC1-Δ90βcat) in which the FoxD3 NC1 enhancer 
(Simões-Costa et al., 2012) drives a β-catenin variant that lacks 
the first 90 amino acids of the mouse protein and is fused to a 
C-terminal EGFP (Wrobel et al., 2007). This construct restricts 
expression of the gain-of-function mutant, which significantly 
up-regulates Wnt reporter output (Fig. S4), to the neural crest 
forming region following specification, in order to bypass del-
eterious effects of Wnt pathway modulation on induction and 
specification events. When coelectroporated with Draxin-FLAG 
(Fig. 8 B), as with hLRP5, neural crest migration was no longer 
adversely affected, and relative migration distance was restored 
to 92.5 ± 6.5% (n = 8) of the unelectroporated side (Fig. 8 C). To-
gether, these data suggest that Draxin acts via LRP5 to modulate 
canonical Wnt signaling to control cranial neural crest EMT pro-
gression (Fig. 8 D).
Discussion
Canonical Wnt signaling has reiterative functions throughout 
different stages of neural crest development, from induction and 
specification to EMT and later differentiation (Wu et al., 2003; 
Yanfeng et al., 2003; Simões-Costa and Bronner, 2015; Simões-
Costa et al., 2015). How it elicits different responses during these 
various events has been unknown. Our data provide the first 
mechanistic evidence that modulation of Wnt signaling output is 
necessary to control the timing and progression of cranial neural 
crest delamination/EMT and that the secreted molecule Draxin 
is a critical modulator of these signaling events.
Our results suggest the following model for the role of Draxin 
in EMT. The process of neural crest EMT can be divided into two 
steps: delamination from the neural tube and mesenchymaliza-
Figure 7. Draxin perturbation altered canonical Wnt reporter expression 
in vivo. (A) Quantitative Western blots compared normalized levels of GFP 
relative to RFP between control MO and Draxin MO–electroporated sides of 
the same embryos, each coelectroporated with a TCF/Lef: H2B -GFP canoni-
cal Wnt reporter construct and grown to HH9. Quantification revealed a sig-
nificant increase in GFP expression when Draxin was knocked down (*, P < 
0.0001; two-tailed t test; n = 12 pooled half embryos). (B) Quantitative West-
ern blots compared normalized levels of GFP relative to RFP between pCI-
H2B-RFP and Draxin-FLAG–electroporated sides of the same embryos, each 
coelectroporated with a TCF/Lef: H2B -GFP canonical Wnt reporter construct 
and grown to HH9. Quantification revealed a significant reduction in GFP 
expression when Draxin-FLAG was overexpressed (*, P = 0.015; two-tailed t 
test; n = 15 pooled half embryos). (C) Representative cross section of embryo 
coelectroporated with TCF/Lef: H2B -GFP (cyan) and pCI-H2B-RFP (left) or 
Draxin-FLAG (right) immunostained for Pax7 (green). To visually compare TCF/
Lef: H2B -GFP reporter expression levels in neural crest cells undergoing EMT, 
Pax7+ cells that have delaminated from the neural tube are circled. Straight 
dotted line indicates the midline. Bar, 20 µm. (D) Quantitation of GFP+ cells 
on pCI-H2B-RFP (left) versus Draxin-FLAG (right) sides of embryo (three sec-
tions/embryo; n = 3 embryos/condition) yielded a significant decrease (*, P = 
0.02; two-tailed t test) in total GFP+ cells on the Draxin-FLAG–electroporated 
side compared with the control side. Data are presented as mean ± SEM.
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tion (Rogers et al., 2013). Onset of Draxin expression within pre-
migratory neural crest attenuates Wnt signaling to prevent early 
delamination. We show that loss of this attenuation can trigger the 
EMT program prematurely, with subsequent deleterious effects 
on cranial neural crest migration. After Draxin loss of function, 
the increase in Snail2 combined with decreased Cad6B causes pre-
mature delamination of neural crest from the dorsal neural tube 
(Fig. 9 A). This premature exit from the neural tube negatively im-
pacts the maintenance of neural crest specifier gene expression 
and prevents up-regulation of the mesenchymal marker, HNK-1. 
Given that Sox9 and Snail2 cooperate to promote completion of 
EMT (Cheung et al., 2005; Liu et al., 2013), this likely explains why 
neural crest cells delaminate but fail to mesenchymalize and mi-
grate away. In contrast, Draxin overexpression causes a decrease 
in Snail2 levels with concomitant increase in Cad6B, impeding 
separation from the neural tube (Fig. 9 B). The interference of 
delamination observed after Draxin overexpression also disrupts 
up-regulation of HNK-1 and, subsequently, completion of EMT.
The effects on Snail2 expression with Draxin perturbation 
strongly correlate with Draxin’s control of Wnt signaling out-
put, given that Snail2 (Slug) has been shown to be a target of the 
canonical Wnt pathway in neural crest (LaBonne and Bronner-
Fraser, 1998; Monsoro-Burq et al., 2005; Wu et al., 2005). This 
suggests that the levels of canonical Wnt signaling are tightly 
regulated and timed for correct progression of the EMT program. 
We hypothesize that premigratory neural crest cells need to re-
main within the neuroepithelium long enough to potentiate their 
transition to a mesenchymal cell type and that Draxin is a critical 
rheostat for regulating Wnt signaling during this process. Inter-
fering with this potentiation by either inhibiting or maintaining 
Draxin results in failure to mesenchymalize and correctly com-
plete the EMT program, thus impeding neural crest migration.
Our finding that a pulse of Draxin expression is required to 
transiently inhibit canonical Wnt within premigratory cranial 
neural crest for completion of EMT is consistent with recent 
work connecting premigratory signaling events with contact in-
hibition of locomotion (CIL; Scarpa et al., 2015). CIL, the process 
by which neural crest cells migrate, is controlled by noncanonical 
(β-catenin independent) Wnt/planar cell polarity (PCP) signal-
ing (De Calisto et al., 2005; Carmona-Fontaine et al., 2008b). We 
Figure 8. Draxin-mediated defects on cranial 
neural crest EMT were rescued by canonical 
Wnt pathway components. (A) Immunos-
taining against Pax7 (green) and LRP5 (cyan) 
in hLRP5 and Draxin-FLAG–coelectroporated 
(magenta) embryos. (B) Immunostaining against 
Pax7 (green) and GFP (cyan) in embryos that were 
coelectroporated with Draxin-FLAG (magenta) 
and a β-catenin gain-of-function mutant con-
struct, which lacks the first 90 amino acids of the 
mouse protein, is fused to a C-terminal EGFP and 
is driven by the FoxD3 NC1 enhancer (NC1-Δ90β-
cat). Bars, 100 µm. (C) Quantification of relative 
maximum migration distance indicated coelec-
troporation of either hLRP5 (n = 6) or NC1-Δ90β-
cat (n = 8) with Draxin-FLAG significantly rescued 
emigration of Pax7+ neural crest cells from Drax-
in-FLAG overexpression. Statistical significance 
was determined using one-way ANO VA with 
Tukey’s post hoc test. *, P = 0.02, P ≥ 0.50. For 
ease of visual comparison, the means of relative 
maximum migration distance for pCI-H2B-RFP 
and Draxin-FLAG from Fig. 4 are presented in this 
figure again as gray circles. Each circle represents 
the average of six measurements per embryo 
taken over a 300-µm anterior-to-posterior region 
of cranial neural crest. Black bars, mean ± SEM. 
(D) Schematic of proposed model for Draxin 
function. When canonical Wnt signaling is active, 
Wnt forms a ternary complex with the Frizzled 
(Fz) and LRP receptors, causing stabilization of 
β-catenin (B-CAT) and its subsequent localization 
to the nucleus, where it functions as a transcrip-
tional activator. When Draxin (D) is present, it 
attenuates canonical Wnt signaling by interacting 
with LRP extracellularly, occluding Wnt/Fz asso-
ciation and resulting in β-catenin degradation, 
which can then no longer activate transcription.
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speculate that perturbation of the degree and timing of canoni-
cal Wnt inhibition may impede the transition from canonical to 
noncanonical Wnt signaling and/or the switch from an epithelial 
to mesenchymal cell type, which may contribute to the negative 
consequences on neural crest migration resulting from altered 
Draxin expression. Further, our work corroborates a recent hy-
pothesis that canonical Wnt signaling has differing effects on 
neural crest delamination and migration (Maj et al., 2016) and 
provides a mechanism for how canonical Wnt is tightly regulated 
in this context.
Recent work in the trunk neural crest has shown that tran-
sient intracellular inhibition of β-catenin–dependent Wnt signal-
ing by the scaffold proteins Dact1/2 is necessary for trunk neural 
crest migration, though not for neural crest motility (Rabadán 
et al., 2016). Our results showing that modulation of Wnt sig-
naling is important for chick cranial neural crest EMT agrees 
with the conclusions of Rabadán et al. (2016), who suggest that 
Wnt signaling needs to be transiently and reversibly inhibited 
for progression of EMT in the chick trunk region. However, the 
mechanisms underlying Wnt modulation appear to differ from 
those observed in our study on cranial neural crest EMT, likely 
because of well-known differences in the EMT mechanisms be-
tween the cranial and trunk neural crest in the chick (del Barrio 
and Nieto, 2002; Théveneau et al., 2007). Interestingly, Dact1/2 
expression in the cranial region appears to be mutually exclusive 
from that of Draxin (Fig. 1); Dact1/2 expression is absent from 
premigratory neural crest cells that are retained within the dor-
sal neural tube and express Draxin but is up-regulated in neural 
crest cells that have delaminated from the neural tube (Alvares 
et al., 2009) when Draxin is down-regulated. This is consistent 
with our findings, where we hypothesize that Draxin would act 
before Dact1/2 as the primary regulator of these Wnt signaling 
events within premigratory neural crest.
Because cranial and trunk neural crest express different ax-
ial-level specific regulatory factors (Simoes-Costa and Bronner, 
2016), it is unsurprising that the mechanisms of neural crest 
EMT and migration may vary between the different axial levels 
(Theveneau and Mayor, 2012). In particular, whereas canonical 
Wnt is important for cranial neural crest EMT, BMP signaling 
integrates with Wnt to regulate trunk neural crest delamina-
tion (Burstyn-Cohen et al., 2004; Kalcheim and Burstyn-Cohen, 
2005). Furthermore, a myriad of extrinsic cues pattern neural 
crest migration and migratory pathways at specific axial lev-
els, although directionality appears to be commonly regulated 
by noncanonical Wnt/PCP signaling (Carmona-Fontaine et al., 
2008a; Theveneau and Mayor, 2012). Thus, it is interesting to 
note that whereas Draxin is expressed in a coordinated pulse 
between neural crest specification and EMT in the cranial re-
gion, its pattern and timing of expression in the trunk appears 
to change later in development, when it is expressed in the roof 
plate and the somites, where it is presumed to influence direc-
tionality of migratory trunk neural crest cells (Su et al., 2009). 
Parsing how Draxin influences signaling in these different con-
texts may provide insights into the control of neural crest EMT 
and migration at different axial levels.
In summary, our results elucidate a mechanism by which 
Draxin functions as a molecular rheostat of canonical Wnt sig-
naling to control the timing of cranial neural crest EMT. Early 
expression of Draxin is required to prevent premature cranial 
neural crest delamination, and its inhibition of Wnt must be ab-
rogated for complete neural crest mesenchymalization and mi-
gration. This novel role for Draxin as an inhibitor of EMT may 
have implications for other cell types that undergo EMT, such as 
metastatic tumor cells, in both development and disease states.
Materials and methods
Experimental model and subject details
Chicken embryos (Gallus gallus) were obtained commercially 
and incubated at 37°C to reach the desired Hamburger–Hamilton 
stage (Hamburger and Hamilton, 1951) as indicated. DF-1 fibro-
blasts were obtained from ATCC (CRL-12203) and maintained at 
37°C/5% CO2 in DMEM supplemented with 10% FBS, 1% l-gluta-
mine, and 1% penicillin-streptomycin.
Figure 9. A model for Draxin’s control of cranial neural crest EMT. (A) 
Under WT conditions, Draxin is expressed in premigratory cranial neural crest 
between stages HH9− and HH9. While Draxin is present (left), tight control 
of canonical Wnt activation and inhibition maintains a balance of Snail2 and 
Cad6B expression, and neural crest cells are retained within the neural tube. 
When Draxin is knocked down (right) before EMT, there is an increase in 
canonical Wnt signaling, which causes an increase in Snail2 and decrease in 
Cad6b; this induces premature delamination of neural crest from the neural 
tube with a subsequent reduction in neural crest cell numbers and migration. 
(B) Under WT conditions, Draxin is down-regulated when cranial neural crest 
becomes migratory at stage HH9+. When Draxin is absent at this stage (left), 
the loss of canonical Wnt inhibition induces Cad6B repression via Snail2, and 
neural crest cells delaminate from the neural tube and mesenchymalize to 
migrate away from the midline. When Draxin is overexpressed at HH9+ (right), 
increased inhibition of canonical Wnt up-regulates levels of Cad6B both within 
the neural tube, reducing neural crest delamination, and in the migratory neu-
ral crest; however, maintenance of Cad6B expression in migratory neural crest 
reduces their mesenchymalization and migratory ability. Yellow circles indi-
cate neural crest cells; orange lines indicate Cad6B.
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Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as de-
scribed (Simões-Costa et al., 2015). Briefly, embryos were 
fixed overnight at 4°C in PBS, pH 7.4, containing 4% PFA, dehy-
drated, and stored in methanol at −20°C before processing. To 
process for chromogenic in situ hybridization, embryos were 
rehydrated with DEPC-PBS/0.1% Tween-20 (PBT), treated 
with 10 µg/ml Proteinase K for 8 min at room temperature, 
washed successively with 2 mg/ml glycine/PBT and PBT, then 
postfixed with 4% PFA/0.2% glutaraldehyde at room tempera-
ture. After several washes of PBT, embryos were incubated 
for at least 3 h before addition of probe at 70°C in hybridiza-
tion solution (Hyb) containing 50% formamide, 1.3× SSC, pH 
5, 5 mM EDTA, pH 8, 200 µg/ml yeast tRNA, 0.2% Tween-20, 
0.5% CHA PS, and 100 µg/ml heparin. Embryos were incubated 
with purified Draxin probe diluted in Hyb (1:300) for at least 
16 h at 70°C. After probe hybridization, embryos were washed 
several times in Hyb at 70°C, then in MABT (1× maleic acid 
buffer/0.1% Tween-20) at room temperature. Embryos were 
blocked in 20% sheep serum/2% Boehringer blocking reagent 
(BBR) in MABT for several hours before addition of anti-di-
goxigenin–AP antibody (1:2,000; Fab fragments; 11093274910; 
Roche). After overnight antibody incubation at 4°C, embryos 
were washed extensively with MABT before chromogenic de-
tection by NBT/BCIP.
To process for fluorescent in situ hybridization, embryos were 
rehydrated with PBT and then treated with 1% hydrogen perox-
ide/PBT for 20 min at room temperature. After several washes 
of PBT, embryos were incubated for at least 3 h before addition 
of probe at 68°C in Hyb. Embryos were incubated with purified 
Draxin probe diluted in Hyb (1:300) at least 16 h at 68°C. After 
hybridization, embryos were washed several times in Hyb at 68°C 
and then in KTBT (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM 
KCl, and 0.2% Tween-20) at room temperature. Embryos were 
blocked in 20% sheep serum/2% BBR in KTBT for several hours 
before addition of anti-digoxigenin–POD antibody (1:1,000; Fab 
fragments; 11207733910; Roche). After overnight antibody incu-
bation at 4°C, embryos were washed extensively with KTBT be-
fore fluorescent tyramide signal amplification (TSA Plus Cyanine 
3 System; Perkin Elmer).
For both chromogenic and fluorescent in situ hybridization, 
digoxigenin-labeled antisense RNA probe was synthesized for 
Draxin (GenBank accession: NM_001142848.2; nucleotides 898–
1,626) using S6 RNA polymerase (Promega) and purified with 
Illustra ProbeQuant G-50 Micro Columns (GE Healthcare).
Whole-mount immunohistochemistry
Whole-mount immunohistochemistry was performed as de-
scribed (Rogers et al., 2013). Briefly, embryos were fixed for 20 
min in 4% PFA in sodium phosphate buffer. Washes and blocking 
buffer (10% donkey serum) used TBSTx (0.5 M Tris-HCl/1.5 M 
NaCl/10  mM CaCl2/0.5% Triton X-100). Embryos were incu-
bated in primary and secondary antibodies for 2 d each at 4°C 
before imaging. Primary reagents used are listed in Table S1. Spe-
cies-specific secondary antibodies were labeled with Alexa Fluor 
350, 488, 568, and 647 (Invitrogen).
Electroporations
Chick embryos were electroporated ex ovo at HH4 as described 
(Sauka-Spengler and Barembaum, 2008; Simões-Costa et al., 
2015). Briefly, embryos were extracted from the eggs using filter 
paper rings and maintained ventral side up in Ringer’s solution 
until electroporation. Specified reagents (constructs, MOs, etc.) 
were injected between the vitelline membrane and epiblast as 
indicated in the text. Embryos were subsequently electropo-
rated using platinum electrodes (five pulses, 6.0 V, 30-ms dura-
tion at 100-ms intervals) and cultured at 37°C in fresh albumin 
supplemented with 1% penicillin-streptomycin to the desired 
Hamburger–Hamilton stage. Embryos cultured in this manner 
occasionally develop with a “curved” phenotype; this is likely an 
artifact of tension sometimes produced by the filter paper and 
does not directly change neural crest development.
Draxin loss of function
Draxin knockdown was performed by CRI SPR/Cas9- or antisense 
MO electroporation. For CRI SPR/Cas9 experiments, Draxin sin-
gle-guide RNA (gRNA [sgRNA]) was designed to target the pro-
tospacer-adjacent motif site adjacent to the start codon using 
the CRI SPR design tool (http:// crispr .mit .edu) and produced 
using the short oligonucleotide method as described (Talbot 
and Amacher, 2014). Briefly, a short guide oligonucleotide was 
designed containing a clamp and T7 promoter sequence, a Draxin 
target sequence, and a sequence overlapping a guide-constant 
oligonucleotide. PCR was performed using AccuPrime Taq Poly-
merase (Thermo Fisher Scientific) with the short guide oligonu-
cleotide, the guide-constant oligonucleotide, and two invariant 
gRNA primers. A single band at 120 bp was gel-extracted using 
the MinElute gel extraction kit (Qiagen), then used as template 
for gRNA transcription using the HiScribe T7 Quick High Yield 
RNA Synthesis Kit (New England Biolabs). For control sgRNA, 
the short guide oligonucleotide contained the clamp and T7 se-
quence, a control sequence designed to have no targets within 
the chick genome (Gandhi et al., 2017), then the guide-constant 
oligonucleotide overlapping sequence. Primer sequences (IDT) 
are listed in Table S2. Before electroporation, control or Draxin 
sgRNA was mixed with recombinant Cas9 (M0646; New England 
Biolabs), heated at 37°C for 15 min, and then diluted with 10 mM 
Tris-HCl, pH 8.5, so that sgRNA and protein were each at a final 
concentration of 0.5 µg/µl for injection.
For MO experiments, a translation-blocking antisense MO 
(Gene Tools; Table S2) was designed to span the Draxin start 
codon starting from nucleotide −5 to +20 (Draxin MO). For con-
trol MO (control MO) experiments, the standard control MO was 
used (Gene Tools). MOs were FITC labeled and coinjected at 1 mM 
concentration with pCIG carrier DNA (Megason and McMahon, 
2002) to improve electroporation efficiency.
Expression vectors
The Draxin-FLAG expression vector was made by first PCR am-
plifying from HH9 cDNA the full-length coding region of Draxin 
(GenBank accession no. NM_001142848.2) using forward (5′-
AAA CTC GAG GCC ACC AGG ATT ATG GCA GCT TCT TCC ACC-3′) and 
reverse (5′-AAA GCT AGC CTA TTA CTT GTC ATC GTC GTC CTT GTA 
GTC AAC ATT AAT GAA TGA TCC CTG CTC TCC AT-3′) primers to in-
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sert an upstream Kozak sequence and C-terminal FLAG epitope 
tag. Draxin-FLAG coding sequence was then cloned into the 
pCI-H2B-RFP expression vector (Betancur et al., 2010b). The 
Draxin-ΔCRD expression vector was made by PCR amplifying 
the truncated form from the Draxin-FLAG expression vector 
(forward, 5′-AAA CTC GAG GCC ACC AGG ATT ATG GCA GCT TCT 
TCC ACC-3′, and reverse, 5′-AAA GCT AGC CTA TTA CTT GTC ATC 
GTC GTC CTT GTA GTC CGG CTC TCC TTC TGC CGA TG-3′) and then 
cloning the fragment into pCI-H2B-RFP. The coding region for 
the CRD-FLAG construct was synthesized as a GeneArt Strings 
DNA fragment (Invitrogen) to include the CRD of Draxin-FLAG as 
well as the amino terminal signal peptide and carboxy terminal 
FLAG. This fragment was then used as a template for PCR ampli-
fication (forward, 5′-AAA CTC GAG GCC ACC AGG ATT ATG GCA GCT 
TCT TCC ACC-3′, and reverse, 5′-AAA GCT AGC CTA TTA CTT GTC 
ATC GTC GTC CTT GTA GTC ACA GCG CCC TTT CCT TCGG-3′) before 
cloning into pCI-H2B-RFP. The CRD-ΔSP construct was made by 
PCR amplifying the CRD from the Draxin-FLAG expression vec-
tor (forward, 5′-AAA CTC GAG GCC ACA ACC TGT GAC CAC CAC CTT 
GAC TGCC-3′, and reverse, 5′-AAA GCT AGC CTA TTA CTT GTC ATC 
GTC GTC CTT GTA GTC ACA GCG CCC TTT CCT TCGG-3′) and then 
cloning the fragment into pCI-H2B-RFP.
To generate the NC1-Δ90βcat construct, the coding for the 
amino terminal-truncated β-catenin was PCR amplified from a 
pCAG-Δ90GFP construct (Wrobel et al., 2007) using 5′-AAA GCT 
AGC GCC ACC ATG GCT CAG AGG GTC CGAG-3′ and 5′-CGG ACA TGT 
ATG GCG ACC GGT GTC CCA GCA GGT CAG TAT CAA ACC AGG CC-3′ 
forward and reverse primers, respectively. This Δ90βcat frag-
ment was then cloned into NC1.1M3 construct upstream of EGFP 
such that Δ90βcat was directly conjugated to EGFP for visualiza-
tion (Simões-Costa et al., 2012).
Cryosectioning
For cross sections, embryos were postfixed overnight at 4°C in 4% 
PFA in sodium phosphate buffer after whole-mount immunohis-
tochemistry or 4% PFA/0.2% glutaraldehyde in PBS after in situ 
hybridization. Embryos were then washed with several changes 
of 5% sucrose in PBS at room temperature and then stored in 15% 
sucrose in PBS overnight at 4°C. Embryos were subsequently 
incubated in 7.5% gelatin for 4–16 h at 37°C and then frozen at 
−80°C. Transverse frozen sections were cut at 20-µm thickness 
and allowed to dry overnight at room temperature. Gelatin was 
removed by incubating slides in PBS at 37°C for 20 min, and cov-
erslips were mounted with Fluoromount-G (SouthernBiotech).
DF-1 cell transfection and processing
Chicken DF-1 fibroblasts were plated in a 100-mm culture 
dish containing an 18-mm round coverslip and grown to 90% 
confluence before transfection. Cells were transfected with 
Draxin-FLAG using Lipofectamine 3000 (Invitrogen), scaled 
according to the manufacturer’s specifications. After overnight 
transfection, cells were washed with PBS and incubated in fresh 
medium overnight. The coverslip was removed, fixed in 4% PFA 
in sodium phosphate buffer for 20 min at room temperature, 
and washed with TBST; nuclei were stained with DAPI (Invi-
trogen); and the coverslip was mounted with Fluoromount-G 
before imaging to confirm transfection, indicated by H2B-RFP 
fluorescence. Conditioned medium was collected, centrifuged to 
remove cellular debris, and concentrated with Amicon Ultra-4 
Centrifugal Filter Units 10,000–molecular weight cutoff (EMD 
Millipore), and protein was extracted with 8 M urea/2.5% SDS. 
Plated cells were washed with PBS, and then cellular proteins 
were extracted with 8 M urea/2.5% SDS. To confirm secretion of 
Draxin, conditioned medium and cellular protein lysates were 
analyzed by Western blot.
Western blots
Embryo lysates were prepared by homogenization in 8  M 
urea/2.5% SDS followed by 15-min incubation at 65°C. Samples 
were loaded (10 µg total protein per well for embryo lysates; 5% of 
volume for DF-1 cells and conditioned media) on Bolt 4–12% Bis-
Tris Plus gels (Invitrogen), and electrophoresis was run accord-
ing to manufacturer specifications. Transfer to nitrocellulose 
was performed in 25 mM Tris/0.2 M glycine/20% methanol for 
1 h at 100 V at 4°C. After transfer, blots were blocked in 5% BSA/
TBSTw (TBS, pH 7.6, and 0.1% Tween-20) for 1 h at room tempera-
ture and then probed with primary antibodies (Table S1) diluted 
in blocking solution overnight at 4°C. Washes were performed 
with TBSTw, and peroxidase-labeled species-specific secondary 
antibodies (KPL/SeraCare) were diluted in 5% milk/TBSTw and 
incubated for 1 h at room temperature. Bands were visualized 
by chemiluminescence (ECL Prime Western Blotting System; GE 
Healthcare) and quantified using ImageJ (64; National Institutes 
of Health). To probe for reference proteins (e.g., RFP and ribo-
somal S6) after visualization of GFP, blots were stripped after 
developing with 2% SDS/0.1M β-mercaptoethanol in 62.5 mM 
Tris-HCl, pH 6.8, for 30 min at 50°C.
Microscope image acquisition
All whole-mount and cross-section images were acquired at 
room temperature using a Zeiss Imager.M2 with an ApoTome.2 
module, Axiocam 506 color and monochromatic cameras, and 
Zen 2 Blue software (ZEI SS). Whole-mount images were acquired 
with a Plan Apochromat 10× objective/0.45 NA (ZEI SS), and em-
bryos were imaged in TBSTx. Cross sections were imaged using 
a Plan Apochromat 20× objective/0.8 NA (ZEI SS), and embryos 
were imaged in Fluoromount-G (SouthernBiotech). Images were 
pseudocolored and minimally processed for brightness and con-
trast using Adobe Photoshop CC.
Image analysis
Relative maximum migration distance
Image analysis was performed in ImageJ. For each whole-mount 
image, the line tool was used to draw and measure a straight 
line from the midline to the farthest point of Pax7+ neural crest 
migration distance. Measurements were made for the unelec-
troporated (left) and electroporated (right) sides at the same 
axial level, and then the electroporated length was divided by 
the unelectroporated length to calculate the relative maximum 
migration distance. Six measurements for each side were taken 
throughout the level of the midbrain at ∼50-µm intervals, and 
the relative maximum migration distances were averaged for in-
dividual embryos. Data points (circles) represent the mean rela-
tive maximum migration distance for single embryos.
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Image analysis was performed on transverse cross sections using 
Fiji (ImageJ; Schindelin et al., 2012). Images were made binary 
and segmented using the watershed function, regions of interest 
(ROIs; e.g. Pax7+ cells) were drawn separately on both the elec-
troporated and unelectroporated sides, and then the Analyze 
Particles function was used to count fluorescently labeled cells 
within each ROI. The relative cell counts were determined by di-
viding the number of fluorescently labeled cells counted on the 
electroporated side by the unelectroporated side for each section 
and averaging three nonadjacent sections per embryo. Data are 
represented as the mean relative cell counts averaged among data 
from three individual embryos.
Relative fluorescence intensity
Image analysis was performed on transverse cross sections using 
ImageJ. Images were background subtracted using a 25-pixel roll-
ing ball radius, ROIs were drawn separately around the cell ROIs 
on both the electroporated and unelectroporated sides, and then 
the integrated density was measured within each ROI. The rel-
ative intensity was determined by dividing the integrated den-
sity on the electroporated side by that on the unelectroporated 
side for each section and averaging three nonadjacent sections 
per embryo. Data are represented as the mean relative intensity 
averaged among data from three individual embryos.
Western blots
Image analysis was performed in ImageJ on scanned images of 
Western blots. Lanes were outlined using the rectangular selec-
tion tool, and bands were plotted using the Plot Lanes function. 
Areas under the peaks were selected using the wand tool and mea-
sured as percentages using the Label Peaks function. GFP and RFP 
bands were normalized by dividing their percentages by their re-
spective ribosomal S6 band percentages and then averaged. The 
mean normalized percentage for GFP was then divided by the 
mean normalized percentage for its respective RFP to control for 
differences in electroporation efficiency. Data are represented as 
the mean relative intensity averaged across three technical repli-
cates (n = 15 pooled half embryos for each experiment).
Statistical analysis
Statistical analyses were performed using Prism (7; GraphPad 
Software). P values are indicated in the text, and a cutoff of P 
< 0.05 was used to determine significance. For all assays com-
paring control pCI-H2B-GFP with Draxin-FLAG, significance was 
assessed using an unpaired two-tailed t test. For all other assays 
of multiple comparisons, P values were calculated using one-way 
ANO VA with Tukey’s post hoc multiple comparisons test to com-
pare individual mutant/rescue experiments with pCI-H2B-RFP 
and Draxin-FLAG. Data are presented as mean values, with error 
bars indicating SEM. Number of embryos/samples and replicates 
are indicated in figure legends and/or text. Data distribution was 
assumed to be normal but was not formally tested.
Online supplemental material
Fig. S1 shows comparison of Draxin knockdown methods. Fig. S2 
shows validation of the Draxin-FLAG construct used in this study. 
Fig. S3 shows amino acid sequence alignments among several spe-
cies for Draxin and compares chick Draxin against human Dkk-1. 
Fig. S4 shows validation of the NC1-Δ90βcat as an activator of 
canonical Wnt signaling. Table S1 contains a list of reagents used 
in this study. Table S2 contains a list of primers used in this study. 
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